These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2652628)

  • 21. Renal transplantation in children less than five years of age.
    Koffman CG; Rigden SP; Bewick M; Chantler C; Haycock GB
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2001-2. PubMed ID: 2652653
    [No Abstract]   [Full Text] [Related]  

  • 22. Some experimental and clinical studies of Cyclosporin A in renal transplantation.
    Morris PJ
    Transplant Proc; 1982 Sep; 14(3):525-8. PubMed ID: 6758238
    [No Abstract]   [Full Text] [Related]  

  • 23. Cyclosporine-associated nephrotoxicity is not intractable.
    Loertscher R
    Transplant Proc; 1987 Aug; 19(4):3486-9. PubMed ID: 3303520
    [No Abstract]   [Full Text] [Related]  

  • 24. Four years' experience with cyclosporine A in pediatric kidney transplantation.
    Hoyer PF; Offner G; Oemar BS; Brodehl J; Ringe B; Pichlmayr R
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):274-9. PubMed ID: 3291256
    [No Abstract]   [Full Text] [Related]  

  • 25. Renal transplantation in children under 5 years of age.
    Laine J; Leijala M; Salmela K; Jalanko H; Sairanen H; Peltola K; Rönnholm K; Eklund B; Wikström S; Holmberg C
    Transplant Proc; 1994 Feb; 26(1):106-9. PubMed ID: 8108896
    [No Abstract]   [Full Text] [Related]  

  • 26. The older living kidney donor: Part of the solution to the organ shortage.
    Gill JS; Gill J; Rose C; Zalunardo N; Landsberg D
    Transplantation; 2006 Dec; 82(12):1662-6. PubMed ID: 17198256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of cadaveric renal donor morbidity on long-term graft function.
    Lovén C; Nordén G; Nyberg G
    Transpl Int; 2003 Dec; 16(12):857-60. PubMed ID: 12920509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. First year renal function as a predictor of kidney allograft outcome.
    Resende L; Guerra J; Santana A; Mil-Homens C; Abreu F; da Costa AG
    Transplant Proc; 2009 Apr; 41(3):846-8. PubMed ID: 19376368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The LifeLink Foundation and cadaver kidney transplantation in Tampa.
    LeFor WM; Wright CE; Bowers VD; Heinrichs DF; Shires DL
    Clin Transpl; 1999; ():149-58. PubMed ID: 11038633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kidney transplantation in the United States.
    Cecka JM
    Clin Transpl; 2008; ():1-18. PubMed ID: 19711510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
    Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Donor source, number of transplants, age at transplant, and diabetes: risk factors in the cyclosporine era.
    Fryd DS; Kruse LV; Simmons RL; Sutherland DE; Payne WD; Najarian JS
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1655-6. PubMed ID: 2652542
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of donor source on renal allograft function in children on triple immunosuppression.
    Laine J; Fyhrquist F; Holmberg C
    Nephrol Dial Transplant; 1994; 9(10):1468-73. PubMed ID: 7816262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal transplantation from donors aged < 6 years into children yields equal graft survival when compared to older donors.
    Filler G; Lindeke A; Böhme K; Devaux S; Schönberger B; Ehrich JH
    Pediatr Transplant; 1997 Nov; 1(2):119-23. PubMed ID: 10084771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Twenty years of renal transplantation in children.
    Potter D; Feduska N; Melzer J; Garovoy M; Hopper S; Duca R; Salvatierra O
    Pediatrics; 1986 Apr; 77(4):465-70. PubMed ID: 3515305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low 1-year cyclosporine microemulsion doses are associated with better 5-year renal graft function: an insight from MOST, a multinational observational study.
    Salvadori M; Rosati A; Bertoni E; Bock A; Chapman J; Dussol B; Fritsche L; Kliem V; Lebranchu Y; Oppenheimer F; Pohanka E; Tufveson G; Soergel M
    Transplant Proc; 2006 May; 38(4):1010-3. PubMed ID: 16757247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal transplant survival from older donors: a single center experience.
    Morrissey PE; Gohh R; Yango A; Gautam A; Monaco AP
    Arch Surg; 2004 Apr; 139(4):384-9; discussion 389. PubMed ID: 15078705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Living donor kidney transplantation: the effects of donor age and gender on short- and long-term outcomes.
    Øien CM; Reisaeter AV; Leivestad T; Dekker FW; Line PD; Os I
    Transplantation; 2007 Mar; 83(5):600-6. PubMed ID: 17353781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different trends in immunosuppression: 10 years' experience with cyclosporine after living related donor renal transplantation.
    Bakr MA; Sally S; Foda MA; Sobh MA; el-Sherif AK; Ghoneim MA
    Transplant Proc; 1994 Dec; 26(6):3163-6. PubMed ID: 7998104
    [No Abstract]   [Full Text] [Related]  

  • 40. Primary cadaveric renal transplantation using cyclosporine in patients over fifty years of age.
    Mandelbaum DM; Henry ML; Sommer BG; Ferguson RM
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1863-4. PubMed ID: 3274443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.